Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Rare childhood blood cancers under the microscope: new registry aims to unlock secrets

NCT ID NCT07410247

First seen Feb 20, 2026 · Last updated May 23, 2026 · Updated 12 times

Summary

This study is creating a nationwide registry and biobank for children and teens diagnosed with rare blood cancers called myeloproliferative neoplasms (MPNs). The goal is to collect medical data and blood samples from 500 participants to better understand how these diseases behave in young people. This information will help doctors improve diagnosis and treatment tailored specifically for children.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHILDHOOD MYELOPROLIFERATIVE NEOPLASMS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany

    RECRUITING

    Erlangen, Bavaria, D-91054, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.